Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 14574 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 24360 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 34885 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 39932 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 96016 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 106379 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 119371 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 123177 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 141051 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 187510 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 194091 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 207632 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 211668 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 241966 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (CAS# 98-92-0); (M+H)+ | 422140 | Peak area | BS4 | IFN-G |